Axithra
Seed Round in 2023
Axithra specializes in therapeutic medication monitoring, specifically focusing on measuring beta-lactam antibiotic concentrations in blood. Its proprietary platform enables personalized treatments by accurately determining drug concentrations, optimizing patient care.
NKT Photonics
Acquisition in 2022
NKT Photonics is a leading manufacturer and developer of high-performance fiber lasers and photonic crystal fibers, serving various markets including medical and life sciences, industrial applications, aerospace and defense, as well as quantum and nanotechnology. The company specializes in products such as OCT imaging systems, pulsed lasers, and ultra-low noise DFB fiber lasers, along with a diverse range of specialty fibers. Their innovative solutions cater to applications in bio-imaging, microscopy, ophthalmology, remote sensing, device characterization, and quality control, among others. Headquartered in Denmark, NKT Photonics operates with a global sales and service network, striving to advance technology across multiple sectors.
NLM Photonics
Venture Round in 2022
NLM Photonics is a semiconductor technology company developing electro-optic modulation technology for transforming networking, computing, and sensing. Based on over two decades of research from the University of Washington, NLM's patented Hybrid Organic Electro-Optic (OEO) Technology enables low-voltage, low-power, high-performance transfer of data between electronics and photonics. This unique solution addresses the bottleneck in signal conversion between electronics and photonics in silicon photonics platforms, offering superior power efficiency and scalable bandwidth.
Armonica Technologies
Series B in 2021
Armonica Technologies is an early-stage medtech company developing a proprietary long-read DNA sequencing platform for precision medicine. The platform uses nanochannels to guide single DNA molecules through nanopores with optical readout by Raman spectroscopy, enabling a complete view of the genome and the detection of epigenetic modifications. It is designed to address limitations of current sequencing technologies for researchers and clinicians, delivering rapid and comprehensive genome information. The company’s technology is based on a portfolio of patented and patent-pending technologies licensed from STC.UNM.
Nanotis
Seed Round in 2021
Nanotis Corporation, founded in 2016 and based in Tokyo, Japan, specializes in the development of instant diagnostic devices aimed at addressing challenges in infectious disease testing, particularly for influenza. The company manufactures microchip-based devices that allow users to quickly and accurately diagnose illnesses. By providing early diagnosis solutions, Nanotis supports medical professionals in practical healthcare settings, thereby enhancing the efficiency of healthcare delivery and improving patient outcomes.
Comptek Solutions
Seed Round in 2018
Comptek Solutions is a Finnish developer specializing in advanced surface engineering for compound semiconductors. Its Kontrox quantum surface engineering process creates defect-free, crystalline surfaces on III-V materials, enabling higher-quality semiconductor devices used in CMOS manufacturing, radio frequency components, optoelectronics, power electronics, and concentrated photovoltaics. Founded in 2017 and based in Turku, the company also offers passivation technologies that mitigate aggressive oxidation, reducing atomic-level defects and improving device efficiency, reliability and manufacturability. Kontrox has demonstrated substantial performance gains in devices such as microLEDs, and the company provides customized services to fit diverse substrate and fabrication flows, helping clients produce more efficient, reliable, and affordable devices across optoelectronics, RF and power electronics markets.
Nanotis
Corporate Round in 2018
Nanotis Corporation, founded in 2016 and based in Tokyo, Japan, specializes in the development of instant diagnostic devices aimed at addressing challenges in infectious disease testing, particularly for influenza. The company manufactures microchip-based devices that allow users to quickly and accurately diagnose illnesses. By providing early diagnosis solutions, Nanotis supports medical professionals in practical healthcare settings, thereby enhancing the efficiency of healthcare delivery and improving patient outcomes.
Energetiq Technology
Acquisition in 2017
Energetiq Technology, Inc. is a leading developer and manufacturer of ultra-bright broadband light sources designed for advanced applications in various fields, including life sciences, materials science, and semiconductor manufacturing. The company specializes in innovative laser-driven light source technology that produces high brightness across a broad spectrum, from 1nm to 1000nm and beyond, ensuring high reliability and extended operating life in a compact design. Energetiq's products are utilized in analytical spectroscopy, microscopy, and sensing, as well as in lithography, metrology, and photoresist development for the semiconductor industry. Founded in 2004 and headquartered in Woburn, Massachusetts, with an additional location in Sunayama-cho, Japan, Energetiq serves a global clientele across the Americas, Europe, the Middle East, Africa, Asia, and Oceania.